These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28083916)

  • 1. Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss: Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy.
    Tracy TE; Gan L
    Bioessays; 2017 Apr; 39(4):. PubMed ID: 28083916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss.
    Tracy TE; Sohn PD; Minami SS; Wang C; Min SW; Li Y; Zhou Y; Le D; Lo I; Ponnusamy R; Cong X; Schilling B; Ellerby LM; Huganir RL; Gan L
    Neuron; 2016 Apr; 90(2):245-60. PubMed ID: 27041503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic Localisation of Tau.
    Hanger DP; Goniotaki D; Noble W
    Adv Exp Med Biol; 2019; 1184():105-112. PubMed ID: 32096032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy.
    Singh B; Covelo A; Martell-Martínez H; Nanclares C; Sherman MA; Okematti E; Meints J; Teravskis PJ; Gallardo C; Savonenko AV; Benneyworth MA; Lesné SE; Liao D; Araque A; Lee MK
    Acta Neuropathol; 2019 Oct; 138(4):551-574. PubMed ID: 31168644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 ameliorates cognitive deficits via regulation of NMDAR expression in an Alzheimer's disease animal model.
    Wan HL; Hong XY; Zhao ZH; Li T; Zhang BG; Liu Q; Wang Q; Zhao S; Wang JZ; Shen XF; Liu GP
    Theranostics; 2021; 11(11):5511-5524. PubMed ID: 33859760
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reelin reverts biochemical, physiological and cognitive alterations in mouse models of Tauopathy.
    Rossi D; Gruart A; Contreras-Murillo G; Muhaisen A; Ávila J; Delgado-García JM; Pujadas L; Soriano E
    Prog Neurobiol; 2020 Mar; 186():101743. PubMed ID: 31870804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau-Induced Elevation of the Activity-Regulated Cytoskeleton Associated Protein Arc1 Causally Mediates Neurodegeneration in the Adult Drosophila Brain.
    Schulz L; Ramirez P; Lemieux A; Gonzalez E; Thomson T; Frost B
    Neuroscience; 2023 May; 518():101-111. PubMed ID: 35487302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
    Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
    J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model.
    Lauretti E; Li JG; Di Meco A; Praticò D
    Transl Psychiatry; 2017 Jan; 7(1):e1020. PubMed ID: 28140402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
    Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
    Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-2 cleavage of tau reversibly impairs memory.
    Zhao X; Kotilinek LA; Smith B; Hlynialuk C; Zahs K; Ramsden M; Cleary J; Ashe KH
    Nat Med; 2016 Nov; 22(11):1268-1276. PubMed ID: 27723722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulating ANP32A rescues synapse and memory loss via chromatin remodeling in Alzheimer model.
    Chai GS; Feng Q; Wang ZH; Hu Y; Sun DS; Li XG; Ke D; Li HL; Liu GP; Wang JZ
    Mol Neurodegener; 2017 May; 12(1):34. PubMed ID: 28472990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease.
    Shao CY; Mirra SS; Sait HB; Sacktor TC; Sigurdsson EM
    Acta Neuropathol; 2011 Sep; 122(3):285-92. PubMed ID: 21630115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies.
    Comerota MM; Tumurbaatar B; Krishnan B; Kayed R; Taglialatela G
    Mol Neurobiol; 2019 May; 56(5):3341-3355. PubMed ID: 30120733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauopathy: A common mechanism for neurodegeneration and brain aging.
    Saha P; Sen N
    Mech Ageing Dev; 2019 Mar; 178():72-79. PubMed ID: 30668956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
    Siman R; Cocca R; Dong Y
    PLoS One; 2015; 10(11):e0142340. PubMed ID: 26540269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bad Ac-etylated Tau.
    Hettinger JC; Cirrito JR
    Neuron; 2016 Apr; 90(2):205-6. PubMed ID: 27100190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
    Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
    Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease.
    Shentu YP; Huo Y; Feng XL; Gilbert J; Zhang Q; Liuyang ZY; Wang XL; Wang G; Zhou H; Wang XC; Wang JZ; Lu YM; Westermarck J; Man HY; Liu R
    Cell Rep; 2018 Jul; 24(3):713-723. PubMed ID: 30021167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.